Nuvilex Inc. and Other Small Cap Oncology Stocks on Fire Leading Up to ASCO Meeting
Press Release: Goldman Small Cap Research, Inc. – 10 hours agoEmail0Share0PrintRELATED QUOTESSymbol Price Change
NVLX 0.0895 0.00
BALTIMORE, MD--(Marketwired - Apr 26, 2013) - Goldman Small Cap Research, a stock market research firm focused on the small cap and micro cap sectors, has produced a research update highlighting the recent performance of Nuvilex Inc. (OTCQB: NVLX) and other small cap oncology stocks. Nuvilex is an international firm engaged in live-cell encapsulation technology to treat pancreatic cancer along with the development and study of the use of #$%$ for the treatment of oncology patients.